Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wu Zi Ding Chuan Wen Fei Hua Tan Tang is a Traditional Chinese Medicine (TCM) herbal decoction formulated to treat respiratory conditions characterized by "Cold-Phlegm" obstructing the lungs, such as chronic obstructive pulmonary disease (COPD), bronchial asthma, and chronic bronchitis. The formula is a specific modification of the classic Wu Zi Ding Chuan Tang, incorporating the "Five Seeds" (typically Perilla, Radish, White Mustard, Bitter Almond, and Descurainia seeds) to descend lung qi and resolve phlegm. It is further enhanced with warming agents like dried ginger and asarum to address underlying cold patterns and improve fluid metabolism in the respiratory tract. Clinical research in China, often conducted in hospital settings, suggests that the decoction can reduce airway inflammation, improve pulmonary function, and alleviate symptoms like wheezing and excessive sputum production during acute exacerbations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on wu zi ding chuan wen fei hua tan tang.